parkinson's%20disease%20-and-%20parkinson's%20disease%20dementia
PARKINSON'S DISEASE & PARKINSON'S DISEASE DEMENTIA

Parkinson's disease is a progressive neurodegenerative disorder that is common, age-related and chronic.

It is caused by loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain.

Onset of symptoms and progression of the disease is gradual.

Motor signs and symptoms include resting tremor, rigidity, bradykinesia and postural instability.

Parkinson's disease dementia indicates loss of intellectual functions including memory, significant deterioration in the ability to carry out day-to-day activities and changes in social behavior are often noted.

Surgical Intervention

Neurosurgery

Pallidotomy

  • Unilateral pallidotomy has been shown to be effective but becomes unfavorable because of its irreversible nature

Deep Brain Stimulation (DBS)

  • Deep brain stimulation using implanted pulse generators in precise brain locations may be performed with specific indication
  • Both subthalamic nuclei (STN) and globus pallidus pars interna deep brain stimulation have shown efficacy in management of Parkinson's disease motor symptoms
  • Thalamic stimulation may be considered as an option in people with Parkinson's disease  who predominantly have severe disabling tremor and where subthalamic nuclei stimulation cannot be performed
  • Good candidates for deep brain stimulation include patients whose motor symptoms are not well controlled by medications or who cannot tolerate side effects of medications, and those who do not have significant active psychiatric or cognitive problems
  • Infection is the most commonly reported side effect of deep brain stimulation
Editor's Recommendations
Most Read Articles
01 Jan 2015
Ginkgo biloba has been shown to improve cognitive as well as neuropsychiatric symptoms (NPS) in patients with Alzheimer’s disease (AD) and mixed dementia. During a Schwabe-sponsored symposium last 20 October 2014 held at the University of Malaya in Malaysia, Professor Serge Gauthier of the McGill Centre for Studies in Aging in Quebec, Canada, and Dr Robert Hoerr of the Dr Willmar Schwabe GmbH & Co. KG in Germany, discussed studies that support the safety and efficacy of Ginkgo biloba extract (EGb 761®) in patients with AD and dementia.
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
Elvira Manzano, 01 Feb 2014

There is no benefit to using ibuprofen over paracetamol in most patients with upper respiratory tract infections (URTIs). Steam inhalation therapy also does not offer any advantage, research has shown.

Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.